共 7 条
[1]
[2]
Levosimendan suppresses oxidative injury; apoptotic signaling and mitochondrial degeneration in streptozotocin-induced diabetic cardiomyopathy[J] Md Sayeed Akhtar;Krishna Kolappa Pillai;Quamrul Hassan;Shahid Husain Ansari;Javed Ali;Mohammed Akhtar;Abul Kalam Najmi Clinical and Experimental Hypertension 2016,
[3]
Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta‐analysis[J] Ju Yong Lim;Salil V. Deo;Abeer Rababa'h;Salah E. Altarabsheh;Yang Hyun Cho;Dustin Hang;Michael McGraw;Edwin G. Avery;Alan H. Markowitz;Soon J. Park J Card Surg 2015,
[4]
A Systematic Review on Levosimendan in Paediatric Patients[J] Simona Silvetti;Paolo Silvani;Maria Luisa Azzolini;Roberto Dossi;Giovanni Landoni;Alberto Zangrillo Current Vascular Pharmacology 2015,
[5]
Management of oral chronic pharmacotherapy in patients hospitalized for acute decompensated heart failure[J] Massimo Piepoli;Simone Binno;Giovanni Quinto Villani;Aderville Cabassi International Journal of Cardiology 2014,
[6]
New pharmacologic therapies for acute heart failure[J] Miguel Tavares;Eva Rezlan;Irina Vostroknoutova;Hosni Khouadja;Alexandre Mebazaa Critical Care Medicine 2008,
[7]
Noninvasive Measurement of Cardiac Output During Exercise by Inert Gas Rebreathing Technique: A New Tool for Heart Failure Evaluation[J] Piergiuseppe Agostoni;Gaia Cattadori;Anna Apostolo;Mauro Contini;Pietro Palermo;Giancarlo Marenzi;Karlman Wasserman Journal of the American College of Cardiology 2005,

